These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12847220)

  • 1. Tumor cells engineered with IL-12 and IL-15 genes induce protective antibody responses in nude mice.
    Orengo AM; Di Carlo E; Comes A; Fabbi M; Piazza T; Cilli M; Musiani P; Ferrini S
    J Immunol; 2003 Jul; 171(2):569-75. PubMed ID: 12847220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combined action of IL-15 and IL-12 gene transfer can induce tumor cell rejection without T and NK cell involvement.
    Di Carlo E; Comes A; Basso S; De Ambrosis A; Meazza R; Musiani P; Moelling K; Albini A; Ferrini S
    J Immunol; 2000 Sep; 165(6):3111-8. PubMed ID: 10975824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissimilar anti-tumour reactions induced by tumour cells engineered with the interleukin-2 or interleukin-15 gene in nude mice.
    Di Carlo E; Meazza R; Basso S; Rosso O; Comes A; Gaggero A; Musiani P; Santi L; Ferrini S
    J Pathol; 2000 Jun; 191(2):193-201. PubMed ID: 10861581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation of endogenously produced interferon gamma in interleukin 4-mediated tumor rejection.
    Nishihori H; Tsuji H; Wang H; Tahara H; Akiyama M; Ogawa Y; Matsushima K; Iwakura Y; Mukaida N
    Hum Gene Ther; 2000 Mar; 11(5):659-68. PubMed ID: 10757346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-21 induces tumor rejection by specific CTL and IFN-gamma-dependent CXC chemokines in syngeneic mice.
    Di Carlo E; Comes A; Orengo AM; Rosso O; Meazza R; Musiani P; Colombo MP; Ferrini S
    J Immunol; 2004 Feb; 172(3):1540-7. PubMed ID: 14734732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40 ligand/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challenge.
    Gurunathan S; Irvine KR; Wu CY; Cohen JI; Thomas E; Prussin C; Restifo NP; Seder RA
    J Immunol; 1998 Nov; 161(9):4563-71. PubMed ID: 9794383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of IL-2 receptor expression and of the biological effects of IL-2 gene transfection in small-cell lung cancer.
    Meazza R; Marciano S; Sforzini S; Orengo AM; Coppolecchia M; Musiani P; Ardizzoni A; Santi L; Azzarone B; Ferrini S
    Br J Cancer; 1996 Sep; 74(5):788-95. PubMed ID: 8795583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-gamma-independent synergistic effects of IL-12 and IL-15 induce anti-tumor immune responses in syngeneic mice.
    Comes A; Di Carlo E; Musiani P; Rosso O; Meazza R; Chiodoni C; Colombo MP; Ferrini S
    Eur J Immunol; 2002 Jul; 32(7):1914-23. PubMed ID: 12115611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TCR vaccines against a murine T cell lymphoma: a primary role for antibodies of the IgG2c class in tumor protection.
    Lambert SL; Okada CY; Levy R
    J Immunol; 2004 Jan; 172(2):929-36. PubMed ID: 14707065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma.
    Mumberg D; Monach PA; Wanderling S; Philip M; Toledano AY; Schreiber RD; Schreiber H
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8633-8. PubMed ID: 10411927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique monoclonal antibodies define expression of Fc gamma RI on macrophages and mast cell lines and demonstrate heterogeneity among subcutaneous and other dendritic cells.
    Tan PS; Gavin AL; Barnes N; Sears DW; Vremec D; Shortman K; Amigorena S; Mottram PL; Hogarth PM
    J Immunol; 2003 Mar; 170(5):2549-56. PubMed ID: 12594281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice.
    Karachunski PI; Ostlie NS; Monfardini C; Conti-Fine BM
    J Immunol; 2000 May; 164(10):5236-44. PubMed ID: 10799884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of multiorgan metastases of human lung cancer cells genetically engineered to produce cytokines and reversal using chimeric monoclonal antibodies in natural killer cell-depleted severe combined immunodeficient mice.
    Sone S; Yano S; Hanibuchi M; Nokihara H; Nishimura N; Miki T; Nishioka Y; Shinohara T
    Cancer Chemother Pharmacol; 1999; 43 Suppl():S26-31. PubMed ID: 10357555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene transfer of a secretable form of IL-15 in murine adenocarcinoma cells: effects on tumorigenicity, metastatic potential and immune response.
    Meazza R; Lollini PL; Nanni P; De Giovanni C; Gaggero A; Comes A; Cilli M; Di Carlo E; Ferrini S; Musiani P
    Int J Cancer; 2000 Aug; 87(4):574-81. PubMed ID: 10918200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell-dependent antitumor effects produced by CD40 ligand expressed on mouse lung carcinoma cells are linked with the maturation of dendritic cells and secretion of a variety of cytokines.
    Tada Y; O-Wang J; Yu L; Shimozato O; Wang YQ; Takiguchi Y; Tatsumi K; Kuriyama T; Takenaga K; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2003 Jun; 10(6):451-6. PubMed ID: 12768190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous IL-12 is necessary for rejection of P815 tumor variants in vivo.
    Fallarino F; Uyttenhove C; Boon T; Gajewski TF
    J Immunol; 1996 Feb; 156(3):1095-100. PubMed ID: 8557984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of NK cell activation by tumor cells on antigen-specific antibody responses.
    Koh CY; Yuan D
    J Immunol; 1997 Nov; 159(10):4745-52. PubMed ID: 9366398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of antitumor immunity by IL-12 gene-transfected AK-5 tumor cells in vivo.
    Nandakumar KS; Lakshmi Rao K; Pardhasaradhi BV; Khar A
    Cytokines Cell Mol Ther; 1999 Mar; 5(1):7-14. PubMed ID: 10390075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 produced by pancreatic carcinoma cells enhances humoral immune responses against tumor cells: a possible event in tumor regression.
    Saito K; Ishikura H; Kishimoto T; Kawarada Y; Yano T; Takahashi T; Kato H; Yoshiki T
    Int J Cancer; 1998 Jan; 75(2):284-9. PubMed ID: 9462720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens.
    Hunter CA; Chizzonite R; Remington JS
    J Immunol; 1995 Nov; 155(9):4347-54. PubMed ID: 7594594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.